$2 billion now seems trivial compared to the *trillions* of dollars of economic damage and stimulus costs from #COVID2019. We need a massive global ⬆️ in R&D funding and innovative financing tools, such as prizes, vouchers, stockpiles, or market-entry awards.

We are thrilled to announce that @Themis_Bio has been acquired by Merck! More here: wsj.com/articles/merck…

Congratulations to our friends at Univercells on yet another incredible year! Like everyone on the planet, we are even more excited about what 2021 will bring... 🎉 @BiologicsforAll 🎉 lecho.be/entreprises/ph…

Simply awesome!

Congrats to our friends at InDevR and Biological E. Limited on the development of yet another much-needed innovation in the vaccine characterization space! 💉🔬🙅‍♀️ measles-rubella 🙅‍♀️🔬💉 Erica Dawson Tenent prnewswire.com/news-releases/…

A look at our growth from Fred Grier in San Diego Business Journal. We launched our #COVID19 test + expanded our team, manufacturing capabilities to meet lab testing demand during the pandemic. Looking forward to our growth this year! (Sub req’d) #pcr #diagnostics ow.ly/RFHS50DeHYs

Congrats to my colleagues Kim Kamdar, Charlie Petty, Lilly deSouza Burr, and Jenny Yip on one of our boldest bets to date: a technology with the potential to cure HIV and other terrible chronic infections. Very excited to begin this journey with @ExcisionBiotx! globenewswire.com/news-release/2…

“As a company focused on science-based innovation to address some of society's most challenging healthcare issues, we are pleased to invest in Adjuvant Capital as part of our holistic global health strategy.” -- Dr. Lutz Hegemann of Novartis fiercebiotech.com/biotech/gates-…

Watch Adjuvant’s Jenny Yip at the WuXi AppTec Healthcare Forum!

👀 linkedin.com/jobs/view/2469…

Adjuvant is hiring an experienced investment associate with a technical background for our San Francisco office! linkedin.com/jobs/view/2469…

Great to see two Adjuvant Capital portfolio companies collaborating on such an important project.

Adjuvant portfolio company VitriVax is hiring a Director of Business Development in Boulder, CO! Apply here: vitrivax.rippling-ats.com/job/266631/dir…

"Our vaccine candidate appears able to block surrogate SARS-CoV-2 replication in the nose before it reaches the lower airways or lungs." 💪💪💪

Thrilled to welcome Josh Adeoye to the Adjuvant team in San Francisco! adjuvantcapital.com/news/josh-adeo…

The first panel of the day featuring keynotes from Qiming Venture Partners @icosavax Adjuvant Capital ArcturusRx Vaxcyte starts 10:00 AM. Join them in Room 1 for "Raising capital – has the pandemic reignited interest in vaccine & immunotherapy biotechs?" #WVIC #Vaccines

Minister of Development Cooperation Caroline Gennez visited the 🇧🇪 Belgian company #Univercells yesterday with 🇰🇪 President William Samoei Ruto, PhD & Minister-President of Wallonia Elio Di Rupo. Read more below ⤵️

Congrats to Adjuvant Capital portfolio company Antiva on successfully closing a "rare" Series E financing to advance their potentially game-changing vaginal tablet treatment for pre-cancerous lesions caused by HPV. 👏👏 Excited to work with @MPMCapital and new CEO Kristine Ball to